Evolent Health Inc (EVH) - Net Assets
Based on the latest financial reports, Evolent Health Inc (EVH) has net assets worth $842.23 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.45 Billion) and total liabilities ($1.61 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Evolent Health Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $842.23 Million |
| % of Total Assets | 34.33% |
| Annual Growth Rate | 55.01% |
| 5-Year Change | 61.6% |
| 10-Year Change | 7.13% |
| Growth Volatility | 149.53 |
Evolent Health Inc - Net Assets Trend (2012–2024)
This chart illustrates how Evolent Health Inc's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Evolent Health Inc for the complete picture of this company's asset base.
Annual Net Assets for Evolent Health Inc (2012–2024)
The table below shows the annual net assets of Evolent Health Inc from 2012 to 2024. For live valuation and market cap data, see Evolent Health Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.00 Billion | -6.22% |
| 2023-12-31 | $1.07 Billion | +24.24% |
| 2022-12-31 | $859.42 Million | +23.90% |
| 2021-12-31 | $693.63 Million | +11.95% |
| 2020-12-31 | $619.60 Million | -33.31% |
| 2019-12-31 | $929.05 Million | -21.89% |
| 2018-12-31 | $1.19 Billion | +13.67% |
| 2017-12-31 | $1.05 Billion | +14.71% |
| 2016-12-31 | $912.11 Million | -2.40% |
| 2015-12-31 | $934.58 Million | +45248.74% |
| 2014-12-31 | $-2.07 Million | -106.67% |
| 2013-12-31 | $31.04 Million | +496.89% |
| 2012-12-31 | $5.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Evolent Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 76023400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.17 Million | 0.12% |
| Other Comprehensive Income | $-1.75 Million | -0.18% |
| Other Components | $1.78 Billion | 178.04% |
| Total Equity | $1.00 Billion | 100.00% |
Evolent Health Inc Competitors by Market Cap
The table below lists competitors of Evolent Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hitron Technologies Inc
TW:2419
|
$306.23 Million |
|
Reconnaissance Energy Africa Ltd
V:RECO
|
$306.26 Million |
|
NVE Corporation
NASDAQ:NVEC
|
$306.29 Million |
|
Bell Financial Group Ltd
AU:BFG
|
$306.38 Million |
|
Kingsway Financial Services Inc
NYSE:KFS
|
$306.16 Million |
|
Selena FM S.A.
WAR:SEL
|
$306.11 Million |
|
CapsoVision, Inc. Common Stock
NASDAQ:CV
|
$306.01 Million |
|
FS Bancorp Inc
NASDAQ:FSBW
|
$305.99 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Evolent Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,067,701,000 to 1,001,259,000, a change of -66,442,000 (-6.2%).
- Net loss of 61,623,000 reduced equity.
- Dividend payments of 20,085,000 reduced retained earnings.
- Share repurchases of 16,624,000 reduced equity.
- Other comprehensive income decreased equity by 496,000.
- Other factors increased equity by 32,386,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-61.62 Million | -6.15% |
| Dividends Paid | $20.09 Million | -2.01% |
| Share Repurchases | $16.62 Million | -1.66% |
| Other Comprehensive Income | $-496.00K | -0.05% |
| Other Changes | $32.39 Million | +3.23% |
| Total Change | $- | -6.22% |
Book Value vs Market Value Analysis
This analysis compares Evolent Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.43x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 27.56x to 0.43x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $0.14 | $3.75 | x |
| 2013-12-31 | $0.81 | $3.75 | x |
| 2014-12-31 | $-0.05 | $3.75 | x |
| 2015-12-31 | $14.07 | $3.75 | x |
| 2016-12-31 | $15.60 | $3.75 | x |
| 2017-12-31 | $15.71 | $3.75 | x |
| 2018-12-31 | $14.79 | $3.75 | x |
| 2019-12-31 | $11.20 | $3.75 | x |
| 2020-12-31 | $7.30 | $3.75 | x |
| 2021-12-31 | $8.06 | $3.75 | x |
| 2022-12-31 | $9.17 | $3.75 | x |
| 2023-12-31 | $9.60 | $3.75 | x |
| 2024-12-31 | $8.73 | $3.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Evolent Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.41%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 2.54x
- Recent ROE (-6.15%) is above the historical average (-30.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -370.37% | -230.81% | 0.51x | 3.13x | $-19.78 Million |
| 2013 | 64.50% | 78.00% | 0.25x | 3.28x | $16.92 Million |
| 2014 | 0.00% | -25.02% | 2.64x | 0.00x | $-25.04 Million |
| 2015 | 51.20% | 343.21% | 0.10x | 1.56x | $267.56 Million |
| 2016 | -22.74% | -62.84% | 0.21x | 1.71x | $-229.99 Million |
| 2017 | -6.00% | -13.95% | 0.33x | 1.30x | $-161.75 Million |
| 2018 | -4.60% | -8.40% | 0.36x | 1.51x | $-167.04 Million |
| 2019 | -32.74% | -43.95% | 0.46x | 1.62x | $-394.21 Million |
| 2020 | -53.95% | -36.15% | 0.63x | 2.38x | $-396.21 Million |
| 2021 | -5.42% | -4.14% | 0.64x | 2.05x | $-106.96 Million |
| 2022 | -2.23% | -1.42% | 0.74x | 2.11x | $-105.11 Million |
| 2023 | -10.59% | -5.76% | 0.73x | 2.51x | $-219.81 Million |
| 2024 | -6.15% | -2.41% | 1.00x | 2.54x | $-161.75 Million |
Industry Comparison
This section compares Evolent Health Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $363,436,353
- Average return on equity (ROE) among peers: -160.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Evolent Health Inc (EVH) | $842.23 Million | -370.37% | 1.91x | $306.16 Million |
| Aclarion Inc (ACON) | $2.23 Million | -317.55% | 0.31x | $1.99 Million |
| American Well Corp (AMWL) | $480.19 Million | -140.60% | 0.23x | $90.87 Million |
| Heartbeam Inc (BEAT) | $-26.87 Million | 0.00% | 0.00x | $30.38 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-3.06 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $612.55 Million | -25.24% | 8.03x | $8.82 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $-70.63 Million | 0.00% | 0.00x | $253.42 Million |
| CareCloud Inc. (CCLD) | $101.25 Million | -8.70% | 0.36x | $117.28 Million |
| Certara Inc (CERT) | $492.05 Million | -1.81% | 1.11x | $983.48 Million |
| CareMax Inc (CMAX) | $61.44 Million | -1112.15% | 9.14x | $381.50 |
| Claritev Corporation (CTEV) | $1.99 Billion | 0.49% | 3.21x | $277.75 Million |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, anal… Read more